Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Amgen Will Acquire Pfizer Plant In Ireland

by Rick Mullin
March 21, 2011 | A version of this story appeared in Volume 89, Issue 12

Amgen has agreed to purchase Pfizer’s facility in Dun Laoghaire, Ireland. The site, near Dublin, is one of three in Ireland that Pfizer announced it would sell after its 2009 purchase of Wyeth. Amgen will continue to manufacture Pfizer products at the site for an interim period, and Pfizer will temporarily lease a bioprocessing suite. Amgen plans to operate Dun Laoghaire as a biologics formulation and fill facility, expanding operations with a syringe filling suite. According to IDA Ireland, the Irish development authority, a majority of the approximately 240 employees at the site will transfer to Amgen.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.